Download FREE Report Sample
Download Free sampleFollicular lymphoma is a cancer that affects white blood cells called lymphocytes. There are two types of lymphomas: Hodgkin's and non-Hodgkin's, based on the kind of white blood cell they affect. Follicular lymphoma is a non-Hodgkin's lymphoma.Drugs for Follicular lymphoma are Anti-CD20 mAbs, Chemotherapy Agents, Kinase Inhibitor, etc.
Follicular Lymphoma Drugs Market contains market size and forecasts of Follicular Lymphoma Drugs in Global, including the following market information:
Global Follicular Lymphoma Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Follicular Lymphoma Drugs market was valued at 1760.6 million in 2021 and is projected to reach US$ 2842.4 million by 2028, at a CAGR of 7.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anti-CD20 mAbs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Follicular Lymphoma Drugs include Roche, Gilead Sciences, TG Therapeutics, Bayer, Secura Bio, Epizyme, Eisai, Acrotech Biopharma and Teva, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Follicular Lymphoma Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Follicular Lymphoma Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Follicular Lymphoma Drugs Market Segment Percentages, by Type, 2021 (%)
Anti-CD20 mAbs
Chemotherapy Agents
Kinase Inhibitor
Others
Global Follicular Lymphoma Drugs Market, by Administration Route, 2017-2022, 2023-2028 ($ millions)
Global Follicular Lymphoma Drugs Market Segment Percentages, by Administration Route, 2021 (%)
Injection
Oral
Global Follicular Lymphoma Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Follicular Lymphoma Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Follicular Lymphoma Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Follicular Lymphoma Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Gilead Sciences
TG Therapeutics
Bayer
Secura Bio
Epizyme
Eisai
Acrotech Biopharma
Teva
Eagle Pharmaceuticals
MundiPharma
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
